| abstract |
Provided are antibodies against hepatitis B surface antigen, coding nucleic acids and preparations thereof, and pharmaceutical compositions comprising the antibodies. Also provided are the use of antibodies and pharmaceutical compositions. Antibodies and pharmaceutical compositions are used to prevent and / or treat HBV infection or diseases associated with HBV infection (eg, hepatitis B), neutralize the toxicity of HBV in the body of a subject (eg, humans), and HBV DNA And / or reduce serum levels of HBsAg. |